Global Central Nervous System (CNS) Biomarkers Market 2015 - Funding from Government and Private Players to Boost CNS Biomarker Market

Dec 14, 2015, 04:45 ET from Research and Markets

DUBLIN, December 14, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/k5tgps/global_central) has announced the addition of the "Global Central Nervous System (CNS) Biomarkers by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering. 
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

In the present scenario, the research and development in CNS market has paced up due to support from government and private players. Additionally, FDA approvals are giving rise to significant scope in biomarker market. Moreover, Technological advancement in the CNS biomarker diagnostics enables to expand CNS biomarker market and innovations are giving rise to growth of CNS biomarker market. 

Presently, the global CNS biomarker market is undergoing rapid expansion with the discovery of new applications and the development of existing technologies. The key driving forces for the global CNS biomarker market are: Development in proteomics, genomics and imaging system in CNS biomarker. 

Funding from government and private players has also strengthened the CNS market. Increase in government spending/ private investment in healthcare budgets and R&D respectively, rising case of lifestyle related diseases and so on. Various factors such as High cost of CNS biomarker test and diagnostics are hindrances for the growth of CNS biomarker market. Reimbursement issues have left CNS biomarker market in doldrums. 

Key Topics Covered: 

1. Introduction 

2. Market overview

3. Market determinants 

4. Sector Analysis 

5. Market Segmentation 

6. Competitive Landscape 

7. Geographical analysis 

8. Company Profiling: - (Over, SWOT analysis, strategic review) 

- Abastar MDX Inc 
- Abiant Inc 
- Acumen pharmaceuticals Inc 
- Adlyfe Inc 
- Alseres pharmaceuticals Inc 
- Apitope international 
- Aposense 
- Applied neurosolutions Inc 
- Avacta group plc 
- Avid radiopharmaceuticals Inc 
- Banyan biomarkers 
- Diagenic ASA 
- EKFdiagnostics holdings inc 
- Enzo biochem inc 
- Exonhit therapeutics 
- Genenews ltd 
- Glycominds ltd 
- Great lakes neurotechnologies 
- Innogenetics biologicals 
- Innovative neurotechnologies inc 
- Merck & co inc 
- Metabolon inc 
- Myriad RBM inc 
- Oligomerix inc 
- Opko health inc 
- Osta biotechnologies inc 
- Proteome sciences products 
- Psynova neurotech ltd 
- Ridge diagnostics 
- Sabiosciences 
- Satori pharmaceutical inc 
- Thermo fisher scientific 

For more information visit http://www.researchandmarkets.com/research/k5tgps/global_central

About Research and Markets:  

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact
Laura Wood
+353-1-481-1716
press@researchandmarkets.net


SOURCE Research and Markets